Study on Tolerability of Repeat i.c.v. Administration of sNN0031 Infusion Solution in Patients With PD

NCT02408562 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
1
Enrollment
INDUSTRY
Sponsor class

Stopped Issues with development and supply of infusion system for delivery of IMP. Prolonged approval process for the clinical study sNN0031-004.

Conditions

Interventions

Sponsor

Newron Sweden AB

Collaborators